KLRS

Edward Miller

Known title: General CounselCIK: 0001619252

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

Kalaris Therapeutics Moves in Pre-Market Amid Low RSI. Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.

this person other insiders at KLRS

Transaction History

KLRS▼ Sell$1K
KLRS▼ Sell$444
KLRS▼ Sell$50
KLRS▼ Sell$180
KLRS▼ Sell$0
KLRS▼ Sell$0
KLRS▼ Sell$237
KLRS▼ Sell$2K
KLRS▼ Sell$588
KLRS▼ Sell$495
KLRS▼ Sell$307
KLRS▼ Sell$321
KLRS▼ Sell$2K
KLRS▼ Sell$560
KLRS▼ Sell$476
KLRS▼ Sell$273
KLRS▼ Sell$315
KLRS▼ Sell$2K
KLRS▼ Sell$568
KLRS▼ Sell$470
KLRS▼ Sell$284
KLRS▼ Sell$268
KLRS▼ Sell$6K
KLRS▼ Sell$873
KLRS▼ Sell$271
KLRS▲ Buy$0
KLRS▼ Sell$3K
KLRS▼ Sell$10K
KLRS▼ Sell$0
KLRS▼ Sell$0
KLRS▼ Sell$21K
KLRS▼ Sell$5K
KLRS▲ Buy$0
KLRS▲ Buy$0
KLRS▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.